As shown in Figure 4G, treatment with BGJ398 significantly (P = 0.016) prolonged survival in the cohort of mice xenografted with leukemias over-expressing FGFR1, but not in the AML group showing low expression of FGFR1 (Figure 4G). Here, FGFR1 is linked to leukemia.